Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001654954-18-003882
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-12 16:05:33
Reporting Period:
2018-04-10
Accepted Time:
2018-04-12 16:05:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1378624 Cellular Biomedicine Group Inc. CBMG Biological Products, (No Disgnostic Substances) (2836) 861032927
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569874 Tao Wen Liu 19925 Stevens Creek Blvd., Suite 100
Cupertino CA 95014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-10 10,400 $15.53 223,476 No 4 M Direct
Common Stock Disposition 2018-04-10 10,400 $20.10 213,076 No 4 S Direct
Common Stock Acquisiton 2018-04-11 12,044 $15.53 225,120 No 4 M Direct
Common Stock Disposition 2018-04-11 12,044 $20.08 213,076 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142) Disposition 2018-04-10 10,400 $0.00 10,400 $15.53
Common Stock Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142) Disposition 2018-04-11 12,044 $0.00 12,044 $15.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,044 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transactions.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.05 to $20.20, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.
  4. This option vested over a period of three years according to the following schedule: 1/3 on December 31, 2015 and 1/3 on each anniversary thereafter. The expiration date of such option is May 6, 2017 or 3 months after the reporting person ceases serving on the board of directors of the registrant, whichever is later.